Today, biosamples are "de-identified" for research
Patient identity is stripped from their donated tumor/tissue
This makes research easier...but it also decreases data quality and prevents direct translation of findings into clinical care.
This is a major problem
for the era of precision medicine.
When your biosamples are de-identified for research...
you have no way to learn what happens, regardless of the potential medical, personal or monetary value.